Glucocorticoid Repression of Inflammatory Gene Expression Shows Differential Responsiveness by Transactivation- and Transrepression-Dependent Mechanisms

por King, Elizabeth M., Chivers, Joanna E., Rider, Christopher F., Minnich, Anne, Giembycz, Mark A., Newton, Robert
Publicado 2013

LPA(1) antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis

por Decato, Benjamin E., Leeming, Diana Julie, Sand, Jannie Marie Bülow, Fischer, Aryeh, Du, Shuyan, Palmer, Scott M., Karsdal, Morten, Luo, Yi, Minnich, Anne
Publicado 2022

Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial

por Brown, Elizabeth A., Minnich, Anne, Sanyal, Arun J., Loomba, Rohit, Du, Shuyan, Schwarz, John, Ehman, Richard L., Karsdal, Morten, Leeming, Diana J., Cizza, Giovanni, Charles, Edgar D.
Publicado 2023

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitia...

por Corte, Tamera J, Lancaster, Lisa, Swigris, Jeffrey J, Maher, Toby M, Goldin, Jonathan G, Palmer, Scott M, Suda, Takafumi, Ogura, Takashi, Minnich, Anne, Zhan, Xiaojiang, Tirucherai, Giridhar S, Elpers, Brandon, Xiao, Hong, Watanabe, Hideaki, Smith, R Adam, Charles, Edgar D, Fischer, Aryeh
Publicado 2021